ZURICH, Feb 17 (Reuters) - Novartis said it will buy U.S.-based CoStim Pharmaceuticals Inc., a privately held biotechnology company focused on harnessing the immune system to eliminate immune-blocking signals from cancer, for an undisclosed price.
The Swiss drugmaker said the move follows increasing evidence pointing to the role of the immune system in controlling cancer.
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
In his 2016 letter to Berkshire Hathaway shareholders, legendary investor Warren Buffett wrote, “Every decade or so, dark clouds will fill the economic skies, and they will briefly rain gold. When downpours of that sort occur, it’s imperative that we ...
Microsoft reported better than anticipated Q3 earnings on Thursday, powered by growth in its cloud products.
Gross said in a post on X to avoid tech, but if you have to invest in the sector, one name stands out.
Rooting for Donald Trump to fail has rarely been this profitable. Just ask a hardy band of mostly amateur Wall Street investors who have collectively made tens of millions of dollars over the past month by betting that the stock price of his social media business — Truth Social — will keep dropping despite massive buying by Trump loyalists and wild swings that often mirror the candidate’s latest polls, court trials and outbursts on Trump Social itself.
Car-rental operator Hertz reported it lost another $200 million due to its EV gamble.
Intel stock dropped 9% after the company reported Q1 earnings. Is it a buy right now?
(Bloomberg) -- Four months into office, Argentine President Javier Milei has pulled off a critical feat in a country long ravaged by runaway inflation: He stabilized the currency.Most Read from BloombergUS Economy Slows and Inflation Jumps, Damping Soft-Landing HopesJavier Milei Fuels Wild Rally That Makes Peso No. 1 in WorldMalaysia in Talks With Tycoons on Casino to Revive $100 Billion Forest CityPlunging Home Prices, Fleeing Companies: Austin’s Glow Is FadingBig Tech Surges in Late Hours on B
As US growth shows signs of sputtering and inflation keeps rising, a re-run of the tumultuous 1970s is looking more likely.
These stocks all deserve to be trading at far higher prices, and it may not be too long before they start to rally.